MXPA06014923A - Usos cosmeticos de radiacion electromagnetica. - Google Patents
Usos cosmeticos de radiacion electromagnetica.Info
- Publication number
- MXPA06014923A MXPA06014923A MXPA06014923A MXPA06014923A MXPA06014923A MX PA06014923 A MXPA06014923 A MX PA06014923A MX PA06014923 A MXPA06014923 A MX PA06014923A MX PA06014923 A MXPA06014923 A MX PA06014923A MX PA06014923 A MXPA06014923 A MX PA06014923A
- Authority
- MX
- Mexico
- Prior art keywords
- skin
- further characterized
- electromagnetic radiation
- wavelength
- radiation
- Prior art date
Links
- 230000005670 electromagnetic radiation Effects 0.000 title claims abstract description 48
- 239000002537 cosmetic Substances 0.000 title claims abstract description 18
- 238000011282 treatment Methods 0.000 claims abstract description 49
- 238000000034 method Methods 0.000 claims abstract description 48
- 230000037303 wrinkles Effects 0.000 claims abstract description 19
- 230000032683 aging Effects 0.000 claims abstract description 12
- 230000001678 irradiating effect Effects 0.000 claims abstract description 7
- 210000001217 buttock Anatomy 0.000 claims abstract description 5
- 210000000689 upper leg Anatomy 0.000 claims abstract description 5
- 230000003467 diminishing effect Effects 0.000 claims abstract description 3
- 210000003739 neck Anatomy 0.000 claims abstract 2
- 210000002784 stomach Anatomy 0.000 claims abstract 2
- 210000003491 skin Anatomy 0.000 claims description 63
- 230000000694 effects Effects 0.000 claims description 21
- 108010047620 Phytohemagglutinins Proteins 0.000 claims description 18
- 230000001885 phytohemagglutinin Effects 0.000 claims description 18
- 230000005855 radiation Effects 0.000 claims description 17
- 210000003819 peripheral blood mononuclear cell Anatomy 0.000 claims description 9
- 210000004698 lymphocyte Anatomy 0.000 claims description 6
- 210000004207 dermis Anatomy 0.000 claims description 5
- 210000002865 immune cell Anatomy 0.000 claims description 4
- 230000002441 reversible effect Effects 0.000 claims description 4
- 230000035899 viability Effects 0.000 claims description 4
- 206010051246 Photodermatosis Diseases 0.000 claims description 2
- 210000002615 epidermis Anatomy 0.000 claims description 2
- 230000008845 photoaging Effects 0.000 claims description 2
- 230000037380 skin damage Effects 0.000 claims description 2
- 230000037394 skin elasticity Effects 0.000 abstract description 6
- 210000000481 breast Anatomy 0.000 abstract description 3
- 230000001815 facial effect Effects 0.000 abstract description 3
- 230000003716 rejuvenation Effects 0.000 abstract description 3
- 230000000979 retarding effect Effects 0.000 abstract description 2
- 210000004027 cell Anatomy 0.000 description 41
- 230000003833 cell viability Effects 0.000 description 25
- 210000001508 eye Anatomy 0.000 description 22
- 230000009467 reduction Effects 0.000 description 12
- 210000001519 tissue Anatomy 0.000 description 10
- 108010035532 Collagen Proteins 0.000 description 8
- 102000008186 Collagen Human genes 0.000 description 8
- 238000000540 analysis of variance Methods 0.000 description 8
- 229920001436 collagen Polymers 0.000 description 8
- 102000004169 proteins and genes Human genes 0.000 description 8
- 108090000623 proteins and genes Proteins 0.000 description 8
- 239000000020 Nitrocellulose Substances 0.000 description 7
- 230000006907 apoptotic process Effects 0.000 description 7
- 210000000170 cell membrane Anatomy 0.000 description 7
- 239000010410 layer Substances 0.000 description 7
- 239000012528 membrane Substances 0.000 description 7
- 229920001220 nitrocellulos Polymers 0.000 description 7
- 108090000672 Annexin A5 Proteins 0.000 description 6
- 102000004121 Annexin A5 Human genes 0.000 description 6
- 230000006872 improvement Effects 0.000 description 6
- 230000001681 protective effect Effects 0.000 description 6
- 210000000744 eyelid Anatomy 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- TZCPCKNHXULUIY-RGULYWFUSA-N 1,2-distearoyl-sn-glycero-3-phosphoserine Chemical group CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCCCCCCCCCCCC TZCPCKNHXULUIY-RGULYWFUSA-N 0.000 description 4
- ZWZWYGMENQVNFU-UHFFFAOYSA-N Glycerophosphorylserin Natural products OC(=O)C(N)COP(O)(=O)OCC(O)CO ZWZWYGMENQVNFU-UHFFFAOYSA-N 0.000 description 4
- 230000005540 biological transmission Effects 0.000 description 4
- 238000003119 immunoblot Methods 0.000 description 4
- 230000001965 increasing effect Effects 0.000 description 4
- 230000007246 mechanism Effects 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 102000003952 Caspase 3 Human genes 0.000 description 3
- 108090000397 Caspase 3 Proteins 0.000 description 3
- 108091005804 Peptidases Proteins 0.000 description 3
- 239000004365 Protease Substances 0.000 description 3
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 230000001413 cellular effect Effects 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 231100000433 cytotoxic Toxicity 0.000 description 3
- 230000001472 cytotoxic effect Effects 0.000 description 3
- 210000002950 fibroblast Anatomy 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- 230000003902 lesion Effects 0.000 description 3
- 238000012423 maintenance Methods 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- NJPPVKZQTLUDBO-UHFFFAOYSA-N novaluron Chemical compound C1=C(Cl)C(OC(F)(F)C(OC(F)(F)F)F)=CC=C1NC(=O)NC(=O)C1=C(F)C=CC=C1F NJPPVKZQTLUDBO-UHFFFAOYSA-N 0.000 description 3
- 238000002203 pretreatment Methods 0.000 description 3
- 230000010076 replication Effects 0.000 description 3
- 238000010186 staining Methods 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 238000001149 thermolysis Methods 0.000 description 3
- 102000007469 Actins Human genes 0.000 description 2
- 108010085238 Actins Proteins 0.000 description 2
- 108091007065 BIRCs Proteins 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- 208000035484 Cellulite Diseases 0.000 description 2
- 230000006820 DNA synthesis Effects 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 102000055031 Inhibitor of Apoptosis Proteins Human genes 0.000 description 2
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 2
- 229930182816 L-glutamine Natural products 0.000 description 2
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 2
- 206010049752 Peau d'orange Diseases 0.000 description 2
- 229920001213 Polysorbate 20 Polymers 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000036232 cellulite Effects 0.000 description 2
- 210000000038 chest Anatomy 0.000 description 2
- 230000001427 coherent effect Effects 0.000 description 2
- 210000004087 cornea Anatomy 0.000 description 2
- 230000000254 damaging effect Effects 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 230000005611 electricity Effects 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 238000003306 harvesting Methods 0.000 description 2
- 230000005923 long-lasting effect Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 238000001126 phototherapy Methods 0.000 description 2
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 2
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 2
- 230000002035 prolonged effect Effects 0.000 description 2
- XJMOSONTPMZWPB-UHFFFAOYSA-M propidium iodide Chemical compound [I-].[I-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CCC[N+](C)(CC)CC)=C1C1=CC=CC=C1 XJMOSONTPMZWPB-UHFFFAOYSA-M 0.000 description 2
- 230000010349 pulsation Effects 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- ZOOGRGPOEVQQDX-UUOKFMHZSA-N 3',5'-cyclic GMP Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=C(NC2=O)N)=C2N=C1 ZOOGRGPOEVQQDX-UUOKFMHZSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 102000018832 Cytochromes Human genes 0.000 description 1
- 108010052832 Cytochromes Proteins 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 1
- 108090001090 Lectins Proteins 0.000 description 1
- 102000004856 Lectins Human genes 0.000 description 1
- 238000003231 Lowry assay Methods 0.000 description 1
- 238000009013 Lowry's assay Methods 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 102000008299 Nitric Oxide Synthase Human genes 0.000 description 1
- 108010021487 Nitric Oxide Synthase Proteins 0.000 description 1
- 102100022397 Nitric oxide synthase, brain Human genes 0.000 description 1
- 101710111444 Nitric oxide synthase, brain Proteins 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 230000006295 S-nitrosylation Effects 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 238000003782 apoptosis assay Methods 0.000 description 1
- 210000000617 arm Anatomy 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000007012 clinical effect Effects 0.000 description 1
- 230000037319 collagen production Effects 0.000 description 1
- 244000221110 common millet Species 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000002900 effect on cell Effects 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 239000002158 endotoxin Substances 0.000 description 1
- 239000002095 exotoxin Substances 0.000 description 1
- 231100000776 exotoxin Toxicity 0.000 description 1
- 210000000887 face Anatomy 0.000 description 1
- 235000013861 fat-free Nutrition 0.000 description 1
- 239000012894 fetal calf serum Substances 0.000 description 1
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 1
- 238000000799 fluorescence microscopy Methods 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 125000001475 halogen functional group Chemical group 0.000 description 1
- 230000003810 hyperpigmentation Effects 0.000 description 1
- 208000000069 hyperpigmentation Diseases 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000003116 impacting effect Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 210000004969 inflammatory cell Anatomy 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 239000011229 interlayer Substances 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 230000000366 juvenile effect Effects 0.000 description 1
- 238000013532 laser treatment Methods 0.000 description 1
- 239000002523 lectin Substances 0.000 description 1
- 210000002414 leg Anatomy 0.000 description 1
- 231100000373 leucotoxic Toxicity 0.000 description 1
- 230000002624 leukotoxic effect Effects 0.000 description 1
- 210000001232 limbus corneae Anatomy 0.000 description 1
- HWYHZTIRURJOHG-UHFFFAOYSA-N luminol Chemical compound O=C1NNC(=O)C2=C1C(N)=CC=C2 HWYHZTIRURJOHG-UHFFFAOYSA-N 0.000 description 1
- 230000000527 lymphocytic effect Effects 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 230000009245 menopause Effects 0.000 description 1
- 239000013586 microbial product Substances 0.000 description 1
- 210000001700 mitochondrial membrane Anatomy 0.000 description 1
- 210000001616 monocyte Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 230000004987 nonapoptotic effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 210000003463 organelle Anatomy 0.000 description 1
- 239000006174 pH buffer Substances 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 230000006461 physiological response Effects 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 150000004032 porphyrins Chemical class 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 230000005522 programmed cell death Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 210000003660 reticulum Anatomy 0.000 description 1
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 1
- YEENEYXBHNNNGV-XEHWZWQGSA-M sodium;3-acetamido-5-[acetyl(methyl)amino]-2,4,6-triiodobenzoate;(2r,3r,4s,5s,6r)-2-[(2r,3s,4s,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound [Na+].CC(=O)N(C)C1=C(I)C(NC(C)=O)=C(I)C(C([O-])=O)=C1I.O[C@H]1[C@H](O)[C@@H](CO)O[C@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 YEENEYXBHNNNGV-XEHWZWQGSA-M 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000003685 thermal hair damage Effects 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 238000001262 western blot Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/18—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
- A61B18/20—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser
- A61B18/203—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser applying laser energy to the outside of the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
- A61B2018/00452—Skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
- A61B2018/00452—Skin
- A61B2018/0047—Upper parts of the skin, e.g. skin peeling or treatment of wrinkles
Landscapes
- Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Optics & Photonics (AREA)
- Surgery (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Otolaryngology (AREA)
- Electromagnetism (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Pathology (AREA)
- Radiology & Medical Imaging (AREA)
- Radiation-Therapy Devices (AREA)
- Cosmetics (AREA)
- Magnetic Treatment Devices (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0414113.1A GB0414113D0 (en) | 2004-06-24 | 2004-06-24 | Cosmetic uses of electromagnetic radiation |
| PCT/GB2005/002433 WO2006000757A1 (en) | 2004-06-24 | 2005-06-21 | Cosmetic uses of electromagnetic radiation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA06014923A true MXPA06014923A (es) | 2007-11-09 |
Family
ID=32800070
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA06014923A MXPA06014923A (es) | 2004-06-24 | 2005-06-21 | Usos cosmeticos de radiacion electromagnetica. |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US9314302B2 (enExample) |
| EP (1) | EP1771225B1 (enExample) |
| JP (1) | JP2008503295A (enExample) |
| KR (1) | KR20070052742A (enExample) |
| CN (1) | CN1988932B (enExample) |
| AT (1) | ATE553816T1 (enExample) |
| AU (1) | AU2005256804B2 (enExample) |
| BR (1) | BRPI0512581B1 (enExample) |
| CA (1) | CA2570919C (enExample) |
| ES (1) | ES2385991T3 (enExample) |
| GB (2) | GB0414113D0 (enExample) |
| MX (1) | MXPA06014923A (enExample) |
| RU (1) | RU2394615C2 (enExample) |
| TR (1) | TR200607363T1 (enExample) |
| UA (1) | UA91681C2 (enExample) |
| WO (1) | WO2006000757A1 (enExample) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6887260B1 (en) | 1998-11-30 | 2005-05-03 | Light Bioscience, Llc | Method and apparatus for acne treatment |
| US9192780B2 (en) * | 1998-11-30 | 2015-11-24 | L'oreal | Low intensity light therapy for treatment of retinal, macular, and visual pathway disorders |
| US20060212025A1 (en) | 1998-11-30 | 2006-09-21 | Light Bioscience, Llc | Method and apparatus for acne treatment |
| US6283956B1 (en) | 1998-11-30 | 2001-09-04 | David H. McDaniels | Reduction, elimination, or stimulation of hair growth |
| JP2006522660A (ja) | 2003-04-10 | 2006-10-05 | ライト バイオサイエンス，エルエルシー | 細胞増殖及び遺伝子発現を調節するためのフォトモジュレーション方法及び装置 |
| KR101160343B1 (ko) | 2003-07-31 | 2012-06-26 | 젠틀웨이브즈 엘엘씨. | 화상, 상처 및 관련 피부 질환의 광역학적 치료 장치 및방법 |
| GB0414113D0 (en) | 2004-06-24 | 2004-07-28 | Virulite Distrib Ltd | Cosmetic uses of electromagnetic radiation |
| GB0512038D0 (en) | 2005-06-14 | 2005-07-20 | Dougal Gordon | Therapeutic and cosmetic uses of electromagnetic radiation |
| US8048089B2 (en) | 2005-12-30 | 2011-11-01 | Edge Systems Corporation | Apparatus and methods for treating the skin |
| US8343116B2 (en) | 2008-01-04 | 2013-01-01 | Edge Systems Corporation | Apparatus and method for treating the skin |
| WO2009052866A1 (en) * | 2007-10-25 | 2009-04-30 | Pantec Biosolutions Ag | Laser device and method for ablating biological tissue |
| WO2009097451A1 (en) | 2008-01-29 | 2009-08-06 | Edge Systems Corporation | Apparatus and method for treating the skin |
| GB0812753D0 (en) * | 2008-07-14 | 2008-08-20 | Dougal Gordon R P | Electromagnetic radiation and its therapeutic effect |
| GB0911740D0 (en) * | 2009-07-07 | 2009-08-19 | Lumicure Ltd | Improved medical apparatus |
| RU2496535C1 (ru) * | 2012-04-19 | 2013-10-27 | Государственное бюджетное образовательное учреждение высшего профессионального образования "Северо-Западный государственный медицинский университет им. И.И. Мечникова" Министерства здравоохранения и социального развития Российской Федерации | Способ коррекции возрастных изменений кожи лица |
| US10589120B1 (en) * | 2012-12-31 | 2020-03-17 | Gary John Bellinger | High-intensity laser therapy method and apparatus |
| EP3903704B1 (en) | 2013-03-15 | 2022-11-02 | HydraFacial LLC | Devices and systems for treating the skin |
| US11083523B2 (en) | 2013-08-09 | 2021-08-10 | The General Hospital Corporation | Method and apparatus for treating dermal melasma |
| US10179229B2 (en) | 2014-12-23 | 2019-01-15 | Edge Systems Llc | Devices and methods for treating the skin using a porous member |
| EP4324414A3 (en) | 2014-12-23 | 2024-05-01 | HydraFacial LLC | Devices and methods for treating the skin using a rollerball or a wicking member |
| WO2019071269A2 (en) | 2017-10-06 | 2019-04-11 | Powell Charles Lee | SYSTEM AND METHOD FOR TREATING AN OBSTRUCTIVE SLEEP APNEA |
| WO2021030280A1 (en) * | 2019-08-13 | 2021-02-18 | Aquavit Pharmaceuticals, Inc. | Methods and compositions for treating dermatological conditions before, during, and/or after electromagnetic radiation treatment |
| US11291474B2 (en) | 2020-01-06 | 2022-04-05 | Ed F. Nicolas | Skin treatment tool applicator tip |
| US11202753B1 (en) | 2020-03-06 | 2021-12-21 | Aquavit Pharmaceuticals, Inc. | Systems and methods for generating immune responses in subjects using microchannel delivery devices |
| US11878167B2 (en) | 2020-05-04 | 2024-01-23 | Btl Healthcare Technologies A.S. | Device and method for unattended treatment of a patient |
| WO2021224678A1 (en) | 2020-05-04 | 2021-11-11 | Btl Medical Technologies S.R.O. | Device and method for unattended treatment of a patient |
| CN112043411A (zh) * | 2020-10-10 | 2020-12-08 | 杨学良 | 一种不开刀无痕去眼袋用定位装置及应用 |
| USD1065551S1 (en) | 2021-09-10 | 2025-03-04 | Hydrafacial Llc | Skin treatment device |
| USD1016615S1 (en) | 2021-09-10 | 2024-03-05 | Hydrafacial Llc | Container for a skin treatment device |
| USD1042807S1 (en) | 2021-10-11 | 2024-09-17 | Hydrafacial Llc | Skin treatment tip |
| US12268443B2 (en) | 2022-10-03 | 2025-04-08 | Kairos Lasers Llc | Therapeutic laser system and method of use for activating the tissue stem cell niche for the treatment of medical conditions |
| USD1084369S1 (en) | 2023-02-10 | 2025-07-15 | Hydrafacial Llc | Skin treatment tip |
Family Cites Families (77)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3473868A (en) * | 1967-04-27 | 1969-10-21 | Space Sciences Inc | Eye position and movement monitor |
| US3533683A (en) * | 1967-06-13 | 1970-10-13 | Whittaker Corp | Dynamic pupillometers using television camera system |
| DE2801552A1 (de) * | 1978-01-14 | 1979-07-19 | Otto Schlueter | Bestrahlungsgeraet fuer den menschlichen koerper |
| DE8120029U1 (de) * | 1981-07-09 | 1983-09-15 | Degischer, Waltraud-Maria, 2000 Hamburg | Infrarot-bestrahlungsgeraet fuer wellenlaengen von ungefaehr 800 bis 1200 nm |
| US4641349A (en) * | 1985-02-20 | 1987-02-03 | Leonard Flom | Iris recognition system |
| US4917084A (en) * | 1985-07-31 | 1990-04-17 | C. R. Bard, Inc. | Infrared laser catheter system |
| US4878891A (en) * | 1987-06-25 | 1989-11-07 | Baylor Research Foundation | Method for eradicating infectious biological contaminants in body tissues |
| US5259380A (en) * | 1987-11-04 | 1993-11-09 | Amcor Electronics, Ltd. | Light therapy system |
| US4930504A (en) * | 1987-11-13 | 1990-06-05 | Diamantopoulos Costas A | Device for biostimulation of tissue and method for treatment of tissue |
| US4858609A (en) * | 1987-12-04 | 1989-08-22 | Cole Roger J | Bright light mask |
| US4931053A (en) * | 1988-01-27 | 1990-06-05 | L'esperance Medical Technologies, Inc. | Method and apparatus for enhanced vascular or other growth |
| US5263951A (en) * | 1989-04-21 | 1993-11-23 | Kerus Medical Systems | Correction of the optical focusing system of the eye using laser thermal keratoplasty |
| US5057716A (en) * | 1989-07-21 | 1991-10-15 | Kueng Martin | Linearly compensated slope multiplier |
| DE4003477A1 (de) | 1990-02-06 | 1991-08-08 | Stefan Reich | Verfahren zur ton- und lichtreizung |
| US5066291A (en) * | 1990-04-25 | 1991-11-19 | Cincinnati Sub-Zero Products, Inc. | Solid-state laser frequency conversion system |
| US5500009A (en) * | 1990-11-15 | 1996-03-19 | Amron, Ltd. | Method of treating herpes |
| US5445146A (en) * | 1995-03-31 | 1995-08-29 | Bellinger; Gary J. | Biological tissue stimulation by low level optical energy |
| US5507716A (en) | 1991-08-21 | 1996-04-16 | The Lucidity Institute, Inc. | Equipment and methods used to induce lucid dreams in sleeping persons |
| CN1032118C (zh) | 1991-09-19 | 1996-06-26 | 周林 | 调节和改善生物生长生存状态的方法及设备 |
| IL100545A (en) * | 1991-12-29 | 1995-03-15 | Dimotech Ltd | Photodynamic Healing Therapy Device |
| US5818048A (en) * | 1992-07-15 | 1998-10-06 | Optix Lp | Rapid non-invasive optical analysis using broad bandpass spectral processing |
| GB9220433D0 (en) * | 1992-09-28 | 1992-11-11 | St George S Enterprises Ltd | Pupillometer |
| US5527350A (en) * | 1993-02-24 | 1996-06-18 | Star Medical Technologies, Inc. | Pulsed infrared laser treatment of psoriasis |
| US5707403A (en) * | 1993-02-24 | 1998-01-13 | Star Medical Technologies, Inc. | Method for the laser treatment of subsurface blood vessels |
| US5849035A (en) * | 1993-04-28 | 1998-12-15 | Focal, Inc. | Methods for intraluminal photothermoforming |
| US5478239A (en) * | 1993-12-21 | 1995-12-26 | Maximum Performance, Inc. | Dynamic visual acuity training method and apparatus |
| US5989245A (en) * | 1994-03-21 | 1999-11-23 | Prescott; Marvin A. | Method and apparatus for therapeutic laser treatment |
| US5464436A (en) * | 1994-04-28 | 1995-11-07 | Lasermedics, Inc. | Method of performing laser therapy |
| IT1274590B (it) | 1994-08-05 | 1997-07-18 | Ambrogio Lazzari | Apparecchiatura multifunzionale per trattamenti estetici |
| US5868731A (en) * | 1996-03-04 | 1999-02-09 | Innotech Usa, Inc. | Laser surgical device and method of its use |
| DE29508077U1 (de) * | 1995-05-16 | 1995-08-10 | Wilden Lutz Dr Med | Mundpflegegerät |
| US5805267A (en) | 1996-06-13 | 1998-09-08 | Goldman; Neil | Interactive light field for programmed non-visual stimulation and monitoring |
| US5879376A (en) * | 1995-07-12 | 1999-03-09 | Luxar Corporation | Method and apparatus for dermatology treatment |
| US5658323A (en) * | 1995-07-12 | 1997-08-19 | Miller; Iain D. | Method and apparatus for dermatology treatment |
| US6159202A (en) * | 1995-09-29 | 2000-12-12 | Nidex Co., Ltd. | Corneal surgery apparatus |
| RU2209031C2 (ru) * | 1995-10-30 | 2003-07-27 | Элти Терапеутикс Корпорейшн | Формирование микропор в коже человека для доставки лекарственных препаратов и мониторинга |
| US5630811A (en) * | 1996-03-25 | 1997-05-20 | Miller; Iain D. | Method and apparatus for hair removal |
| WO1997037602A2 (en) * | 1996-04-09 | 1997-10-16 | Cynosure, Inc. | Alexandrite laser system for treatment of dermatological specimens |
| US5743901A (en) * | 1996-05-15 | 1998-04-28 | Star Medical Technologies, Inc. | High fluence diode laser device and method for the fabrication and use thereof |
| JPH1033549A (ja) * | 1996-07-24 | 1998-02-10 | Shinji Kokubu | レーザプローブ |
| US5913883A (en) * | 1996-08-06 | 1999-06-22 | Alexander; Dane | Therapeutic facial mask |
| US6542081B2 (en) * | 1996-08-19 | 2003-04-01 | William C. Torch | System and method for monitoring eye movement |
| GB9618051D0 (en) | 1996-08-29 | 1996-10-09 | Sls Wales Ltd | Wrinkle removal |
| IL119683A (en) | 1996-11-25 | 2002-12-01 | Rachel Lubart | Method and device for light irradiation into tissue |
| US6063108A (en) * | 1997-01-06 | 2000-05-16 | Salansky; Norman | Method and apparatus for localized low energy photon therapy (LEPT) |
| DE19704197A1 (de) * | 1997-02-05 | 1998-08-06 | Zeiss Carl Jena Gmbh | Anordnung zur subjektivem Refraktionsbestimmung und/oder zur Bestimmung anderer Sehfunktionen |
| US7027869B2 (en) * | 1998-01-07 | 2006-04-11 | Asthmatx, Inc. | Method for treating an asthma attack |
| GB9721506D0 (en) | 1997-10-10 | 1997-12-10 | Virulite Limited | Treatment of diseases |
| US6007202A (en) * | 1997-10-23 | 1999-12-28 | Lasersight Technologies, Inc. | Eye illumination system and method |
| CA2307877C (en) * | 1997-10-30 | 2005-08-30 | The Microoptical Corporation | Eyeglass interface system |
| AU3363999A (en) * | 1998-03-27 | 1999-10-18 | General Hospital Corporation, The | Method and apparatus for the selective targeting of lipid-rich tissues |
| DE29820468U1 (de) | 1998-11-16 | 2000-04-06 | Gelsen Karl Heinz | Gerät zum Beeinflussen des mentalen Zustands |
| US6663659B2 (en) * | 2000-01-13 | 2003-12-16 | Mcdaniel David H. | Method and apparatus for the photomodulation of living cells |
| US6887260B1 (en) * | 1998-11-30 | 2005-05-03 | Light Bioscience, Llc | Method and apparatus for acne treatment |
| US6299308B1 (en) * | 1999-04-02 | 2001-10-09 | Cybernet Systems Corporation | Low-cost non-imaging eye tracker system for computer control |
| DE10049068A1 (de) | 1999-10-04 | 2001-09-27 | Ronald Sroka | Bestrahlungsvorrichtung |
| EP1227768B1 (en) | 1999-10-29 | 2006-10-04 | Neutar, LLC | Method of designing customizable fixture for patient positioning |
| US6113237A (en) * | 1999-12-06 | 2000-09-05 | Ober; Jan Krzysztof | Adaptable eye movement measurement device |
| US6471716B1 (en) * | 2000-07-11 | 2002-10-29 | Joseph P. Pecukonis | Low level light therapy method and apparatus with improved wavelength, temperature and voltage control |
| GB0017051D0 (en) * | 2000-07-11 | 2000-08-30 | Danish Dermatological Dev A S | Improved light guide for coupling light output from a light source to the skin |
| DE10201904B4 (de) | 2001-01-31 | 2013-10-31 | Faromed GmbH Medizintechnik | Verfahren und eine Anordnung zur Vestibularisprüfung des Innenohrs |
| US7753943B2 (en) * | 2001-02-06 | 2010-07-13 | Qlt Inc. | Reduced fluence rate PDT |
| WO2002087700A1 (en) * | 2001-04-26 | 2002-11-07 | The Procter & Gamble Company | Method, kit and device for the treatment of cosmetic skin conditions |
| RU2190436C1 (ru) * | 2001-05-07 | 2002-10-10 | Горбатенкова Елена Александровна | Способ омоложения кожи лица, шеи и тела |
| JP2003016435A (ja) * | 2001-06-27 | 2003-01-17 | Matsushita Electric Ind Co Ltd | 個体認証装置及び方法 |
| CA2487987C (en) | 2002-06-19 | 2010-04-13 | Palomar Medical Technologies, Inc. | Method and apparatus for photothermal treatment of tissue at depth |
| KR200297648Y1 (ko) | 2002-07-12 | 2002-12-12 | 신성하이텍 주식회사 | 휴대용 미용 기구 |
| DE10237620B4 (de) | 2002-08-16 | 2007-06-28 | Ht International Ag | Übertragungsvorrichtung zur Einleitung von Licht in das Ohr |
| US6981970B2 (en) * | 2002-12-16 | 2006-01-03 | Msq (M2) Ltd. | Device and method for treating skin |
| US20040225340A1 (en) * | 2003-03-10 | 2004-11-11 | Evans James W. | Light/breath/meditation device |
| US6974224B2 (en) * | 2003-07-30 | 2005-12-13 | Tru-Light Corporation | Modularized light processing of body components |
| US7549984B2 (en) * | 2004-06-16 | 2009-06-23 | Pneumrx, Inc. | Method of compressing a portion of a lung |
| GB0414113D0 (en) | 2004-06-24 | 2004-07-28 | Virulite Distrib Ltd | Cosmetic uses of electromagnetic radiation |
| EP1835965A1 (en) | 2004-09-08 | 2007-09-26 | Tru-Light Corporation | Universal light processing for a human body |
| US20090216299A1 (en) | 2005-04-06 | 2009-08-27 | Borad Of Trustees Of Michigan State University | System for Low-Level Laser Radiation |
| US7513906B2 (en) * | 2005-05-31 | 2009-04-07 | Medx Health Corp. | Phototherapy apparatus and method for bone healing, bone growth stimulation, and bone cartilage regeneration |
| US7850720B2 (en) | 2006-09-23 | 2010-12-14 | Ron Shefi | Method and apparatus for applying light therapy |
-
2004
- 2004-06-24 GB GBGB0414113.1A patent/GB0414113D0/en not_active Ceased
-
2005
- 2005-06-21 RU RU2007101904/14A patent/RU2394615C2/ru not_active IP Right Cessation
- 2005-06-21 UA UAA200700712A patent/UA91681C2/uk unknown
- 2005-06-21 CN CN2005800211336A patent/CN1988932B/zh not_active Expired - Fee Related
- 2005-06-21 GB GB0512625A patent/GB2415387B/en not_active Expired - Fee Related
- 2005-06-21 ES ES05753177T patent/ES2385991T3/es not_active Expired - Lifetime
- 2005-06-21 TR TR2006/07363T patent/TR200607363T1/xx unknown
- 2005-06-21 AU AU2005256804A patent/AU2005256804B2/en not_active Ceased
- 2005-06-21 CA CA2570919A patent/CA2570919C/en not_active Expired - Fee Related
- 2005-06-21 WO PCT/GB2005/002433 patent/WO2006000757A1/en not_active Ceased
- 2005-06-21 KR KR1020077001632A patent/KR20070052742A/ko not_active Ceased
- 2005-06-21 JP JP2007517443A patent/JP2008503295A/ja active Pending
- 2005-06-21 US US11/570,993 patent/US9314302B2/en active Active
- 2005-06-21 BR BRPI0512581-2A patent/BRPI0512581B1/pt not_active IP Right Cessation
- 2005-06-21 EP EP05753177A patent/EP1771225B1/en not_active Expired - Lifetime
- 2005-06-21 MX MXPA06014923A patent/MXPA06014923A/es active IP Right Grant
- 2005-06-21 AT AT05753177T patent/ATE553816T1/de active
Also Published As
| Publication number | Publication date |
|---|---|
| TR200607363T1 (tr) | 2007-02-21 |
| CN1988932A (zh) | 2007-06-27 |
| BRPI0512581B1 (pt) | 2018-06-12 |
| RU2394615C2 (ru) | 2010-07-20 |
| CN1988932B (zh) | 2012-11-14 |
| GB0512625D0 (en) | 2005-07-27 |
| CA2570919C (en) | 2015-01-06 |
| EP1771225B1 (en) | 2012-04-18 |
| BRPI0512581A (pt) | 2008-03-25 |
| KR20070052742A (ko) | 2007-05-22 |
| RU2007101904A (ru) | 2008-07-27 |
| GB2415387A (en) | 2005-12-28 |
| US9314302B2 (en) | 2016-04-19 |
| UA91681C2 (uk) | 2010-08-25 |
| ATE553816T1 (de) | 2012-05-15 |
| GB2415387B (en) | 2010-05-12 |
| WO2006000757A1 (en) | 2006-01-05 |
| AU2005256804A1 (en) | 2006-01-05 |
| WO2006000757A9 (en) | 2006-02-23 |
| CA2570919A1 (en) | 2006-01-05 |
| EP1771225A1 (en) | 2007-04-11 |
| US20090012508A1 (en) | 2009-01-08 |
| AU2005256804B2 (en) | 2011-05-26 |
| JP2008503295A (ja) | 2008-02-07 |
| GB0414113D0 (en) | 2004-07-28 |
| ES2385991T3 (es) | 2012-08-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2005256804B2 (en) | Cosmetic uses of electromagnetic radiation | |
| AU2007212519C1 (en) | Low intensity light therapy for treatment of retinal, macular, and visual pathway disorders | |
| US20040162596A1 (en) | Methods and apparatus for performing photobiostimulation | |
| JP2005521432A (ja) | 生細胞の光調節のための方法および装置 | |
| Maruyama | Hand rejuvenation using standard intense pulsed light (IPL) in Asian patients | |
| RU2294223C2 (ru) | Способ фотообработки биоткани с индукцией селективного апоптоза | |
| CN212016471U (zh) | 一种低频超快激光色斑治疗装置 | |
| KR20230006481A (ko) | 니아신아미드를 함유하는 조성물을 피부에 도포하면서 광을 조사하는 통합 방식에 의한 미용치료 방법 및 관련 기기 | |
| FR3037810A1 (fr) | Procede et dispositif ultraportable de traitement cosmetique anti-rides et anti-rougeurs de la peau par photomodulation ionophorese et microvibrations | |
| RU47234U1 (ru) | Устройство для электрофореза лекарственных веществ | |
| Chandra et al. | Alternative modality in the treatment of acne vulgaris: Low level laser therapy | |
| Durmuş et al. | Demonstrating the importance of emissivity measurement in determining the doses of light sources on tissue mimicking materials such as Laser, IPL and LED | |
| Green et al. | Low-Level Light Therapy with LEDs | |
| HK40077826A (en) | Method for cosmetic treatment by combined illumination and application of a composition comprising niacinamide, and associated device | |
| Lennox et al. | Intense pulsed light | |
| AU2012200092A1 (en) | Low intensity light therapy for treatment of retinal, macular, and visual pathway disorders |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |